Alzheimer Disease

Showing NaN - NaN of 61

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer, Cognitive Dysfunction, Mild Cognitive Impairment Trial in Ireland, Singapore, United States (Renew NCP-5)

Completed
  • Alzheimer Disease
  • +5 more
  • Renew NCP-5
  • Phoenix, Arizona
  • +11 more
Apr 19, 2022

Alzheimer, Parkinson Disease Trial in United States (Posiphen)

Completed
  • Alzheimer Disease
  • Parkinson Disease
  • Stamford, Connecticut
  • +12 more
May 5, 2022

Alzheimer Trial in Worldwide (Donanemab, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Hoover, Alabama
  • +282 more
Apr 6, 2022

Alzheimer Trial in United States (Bryostatin 1, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Bryostatin 1
  • Placebo
  • Colton, California
  • +18 more
Mar 28, 2022

Alzheimer Trial in Worldwide (COR388 capsule, Placebo capsule)

Completed
  • Alzheimer Disease
  • COR388 capsule
  • Placebo capsule
  • Phoenix, Arizona
  • +92 more
Mar 8, 2022

Alzheimer Trial in United States (troriluzole, Placebo oral capsule)

Completed
  • Alzheimer Disease
  • Phoenix, Arizona
  • +43 more
Feb 15, 2022

Alzheimer, Cognitive Dysfunction, Mild Dementia Trial in United States (SAGE-718)

Completed
  • Alzheimer Disease
  • +2 more
  • Phoenix, Arizona
  • +9 more
Jan 20, 2022

Alzheimer Trial in Worldwide (neflamapimod, )

Completed
  • Alzheimer Disease
  • Long Beach, California
  • +37 more
Sep 28, 2021

Alzheimer Trial in Canada, United States (Simufilam 100 mg oral tablet, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Simufilam 100 mg oral tablet
  • Placebo
  • Gilbert, Arizona
  • +16 more
Sep 27, 2021

Alzheimer Trial in United States (Placebo oral tablet, Simufilam 100 mg tablet, Simufilam 50 mg oral tablet)

Completed
  • Alzheimer Disease
  • Placebo oral tablet
  • +2 more
  • Gilbert, Arizona
  • +8 more
Sep 7, 2021

Late Onset Alzheimer's Disease

Recruiting
  • Alzheimer Disease
  • Blood Draw
  • Late Onset Alzheimer's Disease (LOAD) Neuropsychological Battery Test
  • Washington, District of Columbia
  • +11 more
Aug 11, 2021

Longitudinal Cognitive Assessment by BoCA

Recruiting
  • Alzheimer Disease
  • +6 more
  • Boston Cognitive Assessment (BoCA)
  • Miami, Florida
    Andrey Vyshedskiy
Jul 19, 2021

Alzheimer, Mild to Moderate Alzheimer Trial in United States (GRF6019)

Completed
  • Alzheimer Disease
  • Mild to Moderate Alzheimer Disease
  • Lemon Grove, California
  • +9 more
Jan 8, 2021

Alzheimer Trial in Worldwide (BI 425809 dose 1, BI 425809 dose 2, BI 425809 dose 3)

Completed
  • Alzheimer Disease
  • BI 425809 dose 1
  • +4 more
  • Colton, California
  • +94 more
Oct 16, 2020

Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation,Psychomotor Trial in Australia, United States

Completed
  • Agitation in Patients With Dementia of the Alzheimer's Type
  • +2 more
  • Phoenix, Arizona
  • +61 more
Oct 7, 2020

Alzheimer Trial in United States (Bryostatin, Placebo)

Completed
  • Alzheimer Disease
  • Fresno, California
  • +27 more
Sep 8, 2020

Alzheimer Trial in Worldwide (lecozotan SR (SRA-333))

Completed
  • Alzheimer Disease
  • lecozotan SR (SRA-333)
  • Phoenix, Arizona
  • +82 more
Jul 1, 2020

Alzheimer Trial in Netherlands, United States (DNL747, Placebo)

Completed
  • Alzheimer Disease
  • Miami, Florida
  • +4 more
Feb 25, 2020

Alzheimer Trial in Canada, United States (Placebo Control, ELND005)

Completed
  • Alzheimer Disease
  • Phoenix, Arizona
  • +61 more
Oct 17, 2019

Alzheimer Trial in United States (NPT088, Placebo)

Completed
  • Alzheimer Disease
  • Costa Mesa, California
  • +22 more
Aug 14, 2019

Alzheimer Trial in United States (Crenezumab dose level 1, Crenezumab dose level 2, Crenezumb dose level 3)

Completed
  • Alzheimer Disease
  • Crenezumab dose level 1
  • +3 more
  • Phoenix, Arizona
  • +12 more
Jul 23, 2019

Alzheimer, Cognition Disorders Trial in United States (florbetapir F 18 PET scan)

Completed
  • Alzheimer Disease
  • Cognition Disorders
  • florbetapir F 18 PET scan
  • Glendale, Arizona
  • +74 more
Oct 23, 2018

Dementia, Alzheimer Trial in United States (multicomponent psychosocial intervention, Control arm)

Completed
  • Dementia
  • Alzheimer Disease
  • multicomponent psychosocial intervention
  • Control arm
  • Birmingham, Alabama
  • +4 more
Jan 4, 2016

Alzheimer Trial in United States (Valproate, Placebo)

Completed
  • Alzheimer Disease
  • Sun City, Arizona
  • +45 more
Sep 15, 2014

Alzheimer Trial in United States (aripiprazole)

Completed
  • Alzheimer Disease
  • Tuscaloosa, Alabama
  • +40 more
Nov 7, 2013